
Myriad and SOPHiA Partner on Liquid Biopsy Diagnostic Tool
Myriad Genetics, a leading company in molecular diagnostics and precision medicine, has launched a new global partnership with SOPHiA GENETICS, an AI-driven healthcare technology firm.

Myriad Genetics, a leading company in molecular diagnostics and precision medicine, has launched a new global partnership with SOPHiA GENETICS, an AI-driven healthcare technology firm.

SOPHiA GENETICS, a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant new collaboration with Jessa Ziekenhuis in Hasselt, Belgium.

SOPHiA GENETICS, a cloud-native healthcare technology company and a global leader in data-driven medicine, announced an expansion of its partnership with AstraZeneca. This new, multi-year

SOPHiA GENETICS a cloud-native healthcare technology company and global leader in data-driven medicine, announced the expansion of its ongoing collaboration with AstraZeneca to accelerate the

SOPHiA GENETICS, a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone in the global adoption of its groundbreaking